Informed Consent-fill in

HARMED Hearts — Doctor Informed Consent Worksheet (Generic)
HARMED Hearts • Harmed.LifeSpouses & loved ones exposing the truth Big Pharma tries to hide.

HARMED Hearts

Doctor Informed Consent Worksheet — Antidepressant (Generic)

Patient name:
Date:
Doctor name:
Clinic/Contact:
Drug name (generic):
Brand name:
Class (SSRI/SNRI/etc.):

Part 1 — Basics (doctor completes)

  • Diagnosis/indication:
  • FDA-approved for this condition? ☐ Yes ☐ No (off-label)
  • Starting dose + titration schedule:

Part 2 — FDA Black Box Warning (suicidality)

  • I explained the FDA suicidality warning (higher risk up to age 24; risk when starting/changing doses). Doctor initials:
  • I advised family/loved ones on red flags to monitor and when to seek help. Doctor initials:

Part 3 — Half-Life & Withdrawal

  • I explained this drug’s half-life (___ hours) and how missed/late doses may trigger withdrawal. Doctor initials:
  • We discussed a slow, individualized taper; abrupt stopping is unsafe. Doctor initials:

Part 4 — Receptor Occupancy (pharmacology)

  • I explained approximate transporter occupancy at prescribed dose (e.g., serotonin ~80–90%). Doctor initials:
  • We discussed how high occupancy may relate to emotional blunting and withdrawal severity. Doctor initials:

Part 5 — Side Effects discussed

  • Emotional blunting / reduced empathy. Doctor initials:
  • Sexual dysfunction (desire, arousal, orgasm). Doctor initials:
  • Blood pressure changes / monitoring plan. Doctor initials:
  • Sleep disturbance, sweating, headaches, dizziness. Doctor initials:
  • Weight change (gain or loss). Doctor initials:
  • Serious risks: serotonin syndrome, seizures, heart rhythm changes. Doctor initials:

Part 6 — Pregnancy & Postpartum

  • Risks in pregnancy (neonatal adaptation, preterm/low birth weight) discussed. Doctor initials:
  • Breastfeeding: drug transfer via milk & possible infant withdrawal discussed. Doctor initials:
  • Impact on maternal bonding/emotional responsiveness discussed. Doctor initials:

Part 7 — Monitoring & Follow-Up

  • First follow-up scheduled within weeks.
  • Contact if symptoms worsen/adverse effects:
  • Safety plan (how family responds to red flags) reviewed. Doctor initials:
This worksheet supports informed consent and shared decision-making. It does not replace medical judgment.
Patient signature:
Date:
Clinician signature:
Date:

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *